These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 9216940

  • 21. Acute and chronic pulmonary pressor responses to hypoxia: the role of blunting in acclimatization.
    Ou LC, Sardella GL, Hill NS, Tenney SM.
    Respir Physiol; 1986 Apr; 64(1):81-91. PubMed ID: 3704382
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C, Sassi Y, Hajjar RJ, Hadri L.
    Methods Mol Biol; 2018 Apr; 1816():233-241. PubMed ID: 29987824
    [Abstract] [Full Text] [Related]

  • 24. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 25. Oxygen radicals and substance P in perinatal hypoxia-exaggerated, monocrotaline-induced pulmonary hypertension.
    Chen KH, Lai YL, Chen MJ.
    Chin J Physiol; 2012 Apr 30; 55(2):82-90. PubMed ID: 22559732
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pathophysiological effects of hemodilution in chronic mountain sickness in rats.
    Du HK, Lee YJ, Colice GL, Leiter JC, Ou LC.
    J Appl Physiol (1985); 1996 Feb 30; 80(2):574-82. PubMed ID: 8929601
    [Abstract] [Full Text] [Related]

  • 28. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec 30; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 29. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y, Jin H, Tian W, Wang H, Wang H, Zhao Y, Zhang Z, Meng F.
    Pulm Pharmacol Ther; 2011 Aug 30; 24(4):386-93. PubMed ID: 21396478
    [Abstract] [Full Text] [Related]

  • 30. Strain and sex differences in the cardiopulmonary adaptation of rats to high altitude.
    Ou LC, Smith RP.
    Proc Soc Exp Biol Med; 1984 Nov 30; 177(2):308-11. PubMed ID: 6237368
    [Abstract] [Full Text] [Related]

  • 31. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY, Lee JH, Huh JW, Kim HJ, Park MK, Ro JY, Oh YM, Lee SD, Lee YS.
    Am J Respir Cell Mol Biol; 2012 Nov 30; 47(5):698-708. PubMed ID: 22842494
    [Abstract] [Full Text] [Related]

  • 32. Ventilatory and hematopoietic responses to chronic hypoxia in two rat strains.
    Ou LC, Chen J, Fiore E, Leiter JC, Brinck-Johnsen T, Birchard GF, Clemons G, Smith RP.
    J Appl Physiol (1985); 1992 Jun 30; 72(6):2354-63. PubMed ID: 1629091
    [Abstract] [Full Text] [Related]

  • 33. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
    Kawai M, Zhang E, Kabwe JC, Okada A, Maruyama J, Sawada H, Maruyama K.
    BMC Pulm Med; 2022 Mar 05; 22(1):78. PubMed ID: 35247989
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
    Suzuki R, Maehara R, Kobuchi S, Tanaka R, Ohkita M, Matsumura Y.
    Life Sci; 2012 Oct 15; 91(13-14):693-8. PubMed ID: 22542556
    [Abstract] [Full Text] [Related]

  • 35. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 36. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
    Hacker AD.
    Biochem Pharmacol; 1993 Jun 22; 45(12):2475-81. PubMed ID: 8328985
    [Abstract] [Full Text] [Related]

  • 37. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Jun 22; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 38. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Luo L, Lin T, Zheng S, Xie Z, Chen M, Lian G, Xu C, Wang H, Xie L.
    Clin Exp Hypertens; 2015 Jun 22; 37(3):241-8. PubMed ID: 25271670
    [Abstract] [Full Text] [Related]

  • 39. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH.
    Int Immunopharmacol; 2016 Nov 22; 40():196-202. PubMed ID: 27611861
    [Abstract] [Full Text] [Related]

  • 40. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC, Wilson DW, Segall HJ.
    Toxicology; 1993 Mar 30; 79(1):21-35. PubMed ID: 8475497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.